Science Explorer Interactive view Map
Company · Dublin · United States

Navidea Biopharmaceuticals (United States)

navidea.comROR OpenAlex
Research works
49
▼ 4% vs 2013–17
Citations
318
6.5 per fractional work
Top-10% rate
4.2%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Navidea Biopharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.84× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 14.03× its world share, 1 worksImmunology and Micro…Neuroscience: 0.85× its world share, 0 worksNeuroscienceComputer Science: 1.30× its world share, 1 worksComputer ScienceEngineering: 1.30× its world share, 2 worksEngineeringEnvironmental Science: 1.66× its world share, 1 worksEnvironmental ScienceMathematics: 0.39× its world share, 0 worksMathematicsMedicine: 1.37× its world share, 2 worksMedicineDecision Sciences: 0.57× its world share, 0 worksDecision SciencesSocial Sciences: 0.33× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.0×. Every wedge is a field page.

Who are the top researchers at Navidea Biopharmaceuticals (United States)?

Ranked on the composite score, Naveen Dakappagari and Frederick O. Cope lead among researchers whose main affiliation is Navidea Biopharmaceuticals (United States).

  1. 1 Naveen Dakappagari United States · #965,679 worldwide 30 citations · 20 works
  2. 2 Frederick O. Cope United States · #1,044,148 worldwide 21 citations · 18 works
All ranked researchers at Navidea Biopharmaceuticals (United States)

Which keywords describe research at Navidea Biopharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, PET Imaging, Cancer, Immunotherapy, Radioimmunotherapy, Radiopharmaceuticals, Lymphoma and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy7▲ 63×3 topics
  2. PET Imaging6▲ 55×2 topics
  3. Cancer5▲ 7.0×7 topics
  4. Immunotherapy4▲ 13×10 topics
  5. Inflammation4▲ 3.5×11 topics
  6. Radioimmunotherapy4▲ 187×1 topic
  7. Radiopharmaceuticals4▲ 187×1 topic
  8. Lymphoma4▲ 48×2 topics
  9. Tumor Microenvironment3▲ 17×3 topics
  10. Immunity3▲ 17×4 topics
  11. Survival Analysis3▲ 22×3 topics
  12. Gene Expression3▲ 9.2×3 topics
  13. Immune Checkpoint Blockade3▲ 101×1 topic
  14. PD-1 and PD-L13▲ 101×1 topic
  15. Cancer Immunotherapy3▲ 37×2 topics
  16. Cancer Genomics2▲ 94×1 topic
  17. Mutational Signatures2▲ 94×1 topic
  18. Radiotherapy2▲ 14×5 topics
  19. Rituximab2▲ 32×2 topics
  20. Classification2▲ 13×2 topics
  21. Neoadjuvant Therapy2▲ 22×4 topics
  22. Clinical Practice Guidelines2▲ 8.1×3 topics
  23. Genetic Pathogenesis2▲ 74×1 topic
  24. Molecular Profiling2▲ 37×1 topic
  25. Molecular Subtypes2▲ 49×2 topics
  26. Breast Tumours2▲ 78×1 topic
  27. Treatment Response2▲ 78×1 topic
  28. Chemotherapy2▲ 5.3×7 topics
  29. Monoclonal Antibodies2▲ 25×2 topics
  30. Tumor Regression2▲ 42×2 topics
  31. Metabolism2▲ 5.4×2 topics
  32. Glycosylation2▲ 14×2 topics
  33. Precision Medicine2▲ 11×2 topics
  34. Imaging2▲ 8.4×1 topic
  35. PET/CT2▲ 39×1 topic
  36. Prognostic Factors2▲ 6.8×4 topics
  37. Fc Receptors1▲ 28×1 topic
  38. Medical Imaging1▲ 11×1 topic
  39. Radiomics1▲ 45×1 topic
  40. Therapeutic Antibodies1▲ 22×1 topic

Which research topics does Navidea Biopharmaceuticals (United States) publish most on?

By volume in 2022–2025: Wastewater Treatment and Nitrogen Removal, Nanoplatforms for cancer theranostics, Industrial Automation and Control Systems and Immune cells in cancer.

Wastewater Treatment and…1Wastewater Treatment and Nitrogen Removal: 1 fractional worksNanoplatforms for cancer…1Nanoplatforms for cancer theranostics: 1 fractional worksIndustrial Automation and Control Systems: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksBluetooth and Wireless C…1Bluetooth and Wireless Communication Technologies: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksRadiomics and Machine Learning in Medical Imaging: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
PollutionBiomedical EngineeringControl and Systems EngineeringImmunology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Wastewater Treatment and Nitrogen Removal Pollution 1 works
  2. 2 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  3. 3 Industrial Automation and Control Systems Control and Systems Engineering 1 works
  4. 4 Immune cells in cancer Immunology 1 works
  5. 5 Bluetooth and Wireless Communication Technologies Computer Networks and Communications 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 Single-cell and spatial transcriptomics Molecular Biology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.8%not open65.2%

World: 28% of research is openly available.

with international co-authors13.7%domestic only86.3%

World: 19% is written across borders.

How has Navidea Biopharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 4% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dublin

All research institutions in Dublin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.